Acquisition and Loss of Developmental Milestones and Time to Disease-Related Outcomes in Cerebral Alexander Disease
Journal of Child Neurology · 2023
DOI: 10.1177/08830738231210040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child Neurology, 2023. Verfasst von Joshua Joung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Alexander Disease, Megalencephaly. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: NINDS NIH HHS, Elise's Corner, Grayson's Ladder.
Abstract (Originalsprache)
Objective
To determine the ages at acquisition of developmental milestones, loss of motor function, and clinical symptoms in Alexander disease.
Methods
Patients with confirmed cerebral Alexander disease were included. Data abstraction of developmental and disease-specific milestones was performed from medical records, physical exams, and questionnaires. Mixed effects logistic regression was used to determine if key clinical features were associated with milestone achievement, controlling for patient age.
Results
51 patients with cerebral/infantile Alexander disease were evaluated at a mean age of 10.96 years (range 2.29-31.08 years). Developmental milestones in Alexander disease were often achieved but delayed. Ambulation was achieved in 44 subjects (86%); 34 (67%) subjects walked independently (mean age 1.9 years, range 0.91-3.25 years) and an additional 10 (20%) subjects walked with assistance (mean age 3.9 years, range 1.8-8 years) but did not progress to independent ambulation. Developmental delay was the earliest and most prevalent symptom (N = 48 [94%], mean age 0.58 years), compared to an initial seizure (N = 41 [80%], mean age 2.80 years), and macrocephaly (N = 28 [55%], mean age 4.04 years), P < .0001 between these ages of onset. Loss of independent ambulation occurred in 11 of the 34 (32%) children who had acquired ambulation (range 3.41-15.10 years). Presence of seizures or macrocephaly did not predict the achievement or loss of ambulation.
Conclusions
The clinical triad of developmental delay, seizures, and macrocephaly are not universally present in cerebral Alexander disease. Clinicians should have a high index of suspicion for Alexander disease in patients with mild delays and a first seizure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Biostatistics and Data Management Core, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Departments of Neurology and Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Nicholas Vigilante, Amy T Waldman
Förderung
- NINDS NIH HHS
- Elise's Corner
- Grayson's Ladder
- National Institute of Neurological Disorders and Stroke
- Ionis Pharmaceuticals
- Pennsylvania Department of Health
Zitieren
APA
Joung, J., Gallison, K., Sollee, J. J., Vigilante, N., Cooper, H., Liu, G. W., Ballester, L., Faig, W., & Waldman, A. T. (2023). Acquisition and Loss of Developmental Milestones and Time to Disease-Related Outcomes in Cerebral Alexander Disease. Journal of Child Neurology. https://doi.org/10.1177/08830738231210040
Vancouver
Joung J, Gallison K, Sollee JJ, Vigilante N, Cooper H, Liu GW, et al. Acquisition and Loss of Developmental Milestones and Time to Disease-Related Outcomes in Cerebral Alexander Disease. Journal of Child Neurology. 2023. doi:10.1177/08830738231210040
BibTeX
@article{Joung2023,
author = {Joung, Joshua and Gallison, Kathryn and Sollee, John Jack and Vigilante, Nicholas and Cooper, Hannah and Liu, Geraldine W and Ballester, Lance and Faig, Walter and Waldman, Amy T},
title = {Acquisition and Loss of Developmental Milestones and Time to Disease-Related Outcomes in Cerebral Alexander Disease},
journal = {Journal of Child Neurology},
year = {2023},
doi = {10.1177/08830738231210040}
}
EUVIMED